Cellectis S.A. - American Depositary Shares (CLLS) analyst actions
Rating and price-target actions on CLLS in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the CLLS overview →
1 measured CLLS analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Cellectis S.A. (CLLS) And Encourages Stockholders to Reach Out | Press release | -0.33% | +0.00% |
Keep exploring
More CLLS: earnings → · SEC filings → · CLLS overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Fate Therapeutics, Inc. (FATE) | 287 | -0.76% | 39% |
| RenovaCare, Inc. (RCAR) | 286 | 0.00% | 41% |
| Prestige Consumer Healthcare Inc. (PBH) | 285 | -0.11% | 45% |
| Xencor, Inc. (XNCR) | 285 | +0.09% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.